Clinical Trial Update: Evaluation of the Presence of SENS-401 in the Perilymph [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completion evaluating the presence of SENS-401 in the perilymph for hearing loss; results were posted on 2025-04-23.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Drugs mentioned

• SENS-401

Snippet

Sponsor: Sensorion | Conditions: Hearing Loss | Phase 2 | Status: COMPLETED | Results posted: 2025-04-23